GlobeNewswire Inc.··NaKyntra Bio Set to Report 2025 Results as Pipeline Advances in Oncology
Kyntra Bio will report fourth quarter and full year 2025 financial results on March 16, 2026, as the biopharmaceutical company advances its oncology and rare disease pipeline.
KYNBfinancial resultsrare disease